scholarly journals Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus‐related hepatocellular carcinoma after surgical resection: A multicenter study

2021 ◽  
Author(s):  
Weili Qi ◽  
Junyi Shen ◽  
Junlong Dai ◽  
Youwei Wu ◽  
Yu Zhang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
Multicenter Study ◽  
Nucleotide Analogs ◽  
B Virus

Abstract 718: microRNA-29a* is a predictor for early recurrence hepatitis B virus-related hepatocellular carcinoma after surgical resection

2012 ◽  
Author(s):  
Hai-Tao Zhu ◽  
Qiong-Zhu Dong ◽  
Yuan-Yuan Sheng ◽  
Jin-Wang Wei ◽  
Guan Wang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
Early Recurrence ◽  
B Virus

scholarly journals Long-term oncologic outcomes of liver resection for hepatocellular carcinoma in adolescents and young adults: A multicenter study from a hepatitis B virus-endemic area

2021 ◽  
Vol 25 (1) ◽  
pp. S241-S241
Author(s):  
Yong-Kang DIAO ◽  
Jun-Wei LIU ◽  
Wan Yee LAU ◽  
Xin-Ping FAN ◽  
Ting-Hao CHEN ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Young Adults ◽  
Hepatitis B Virus ◽  
Liver Resection ◽  
Hepatitis B ◽  
Multicenter Study ◽  
Endemic Area ◽  
Oncologic Outcomes ◽  
B Virus

Letter to the Editors: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection

Hepatology ◽  
2020 ◽  
Author(s):  
Guandou Yuan ◽  
Jianni Yao ◽  
Jingjing Yu ◽  
Xuemei Xie ◽  
Songqing He
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
B Virus

scholarly journals Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0201316 ◽  
Author(s):  
Baek Gyu Jun ◽  
Young Don Kim ◽  
Sang Gyune Kim ◽  
Young Seok Kim ◽  
Soung Won Jeong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Multicenter Study ◽  
Antiviral Treatment ◽  
Virus Reactivation ◽  
Hepatitis B Virus Reactivation ◽  
B Virus

scholarly journals Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection

PLoS ONE ◽  
2020 ◽  
Vol 15 (11) ◽  
pp. e0242748
Author(s):  
Chiao-Fang Teng ◽  
Tsai-Chung Li ◽  
Hsi-Yuan Huang ◽  
Wen-Ling Chan ◽  
Han-Chieh Wu ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
Deletion Mutations ◽  
B Virus ◽  
Improve Patient ◽  
Generation Sequencing ◽  
Hcc Recurrence ◽  
Poor Patient Survival

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Despite curative surgical resection, high recurrence of HCC after surgery results in poor patient survival. To develop prognostic markers is therefore important for better prevention and therapy of recurrent HCC to improve patient outcomes. Deletion mutations over the pre-S1 and pre-S2 gene segments of hepatitis B virus (HBV) have been closely associated with recurrence of HCC after curative surgical resection. In this study, we applied a next-generation sequencing-based approach to further evaluate the association of pre-S deletion regions with HCC recurrence. We demonstrated that the pre-S2 deletion (nucleotide 1 to 54) was the most predominant deletion regions of pre-S gene in plasma of HBV-related HCC patients. Moreover, patients with the pre-S2 deletion (nucleotide 1 to 54) exhibited a significantly higher risk of HCC recurrence after curative surgical resection than those without. The pre-S2 deletion (nucleotide 1 to 54) in plasma represented a prognostic factor that independently predicted HCC recurrence with greater performance than other clinicopathological and viral factors. Our data suggest that detection of the pre-S2 deletion (nucleotide 1 to 54) in plasma may be a promising noninvasive strategy for identifying patients at high risk for HCC recurrence after curative surgical resection.

Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis

2007 ◽  
Vol 41 (12) ◽  
pp. 1206-1213 ◽  
Author(s):  
Takashi Someya ◽  
Kenji Ikeda ◽  
Satoshi Saitoh ◽  
Masahiro Kobayashi ◽  
Tetsuya Hosaka ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Pilot Study ◽  
Hepatitis B ◽  
Recurrence Rate ◽  
Surgical Resection ◽  
Tumor Recurrence ◽  
B Virus ◽  
Tumor Recurrence Rate

scholarly journals MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection

PLoS ONE ◽  
2012 ◽  
Vol 7 (12) ◽  
pp. e52393 ◽  
Author(s):  
Hai-Tao Zhu ◽  
Qiong-Zhu Dong ◽  
Yuan-Yuan Sheng ◽  
Jin-Wang Wei ◽  
Guan Wang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
Early Recurrence ◽  
B Virus

Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Surgical Resection

Hepatology ◽  
2020 ◽  
Author(s):  
Jonggi Choi ◽  
Chanyoung Jo ◽  
Young‐Suk Lim
Keyword(s):  
Hepatocellular Carcinoma ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Surgical Resection ◽  
B Virus
Sign in / Sign up

Export Citation Format

Share Document